Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 5131-5140 Newer>

BusinessWeek January 17, 2005 Weintraub & Barrett	Waking Up The Insomnia Market On Dec. 16, Sepracor Inc. won approval from the Food & Drug Administration to market Lunesta, a new sleep aid. Giddy investors pushed Sepracor's stock up 16%, to $60, in the two weeks following the news.
BusinessWeek January 17, 2005 Robert Barker	The Monday Morning Quarterback Report A look back at columns at least one year old to find those that time and events proved wrong.
BusinessWeek January 17, 2005 Gene G. Marcial	Marathon's Bright Flame Although Marathon Oil has trailed its peers amid rising crude-oil prices, some pros say it's the play for the long run.
BusinessWeek January 17, 2005 Joseph Weber	E*Trade Rises From The Ashes The online broker is back in the black thanks to its ultra disciplined CEO Mitchell H. Caplan.
BusinessWeek January 17, 2005 Gene G. Marcial	Why Movado Is Ticking Right Along No major street analyst follows Movado Group, but a number of money managers are high on the watchmaker, pushing the stock up from 13.64 in August to 17.74 on Jan. 5
BusinessWeek January 17, 2005 Gene G. Marcial	Cornell May Be Poised For A Breakout There's unrest at Cornell, a provider of operational services, including medical treatment and education, to 70 federal and local prisons in 13 states.
BusinessWeek January 17, 2005	Too Many Ways To Expense Options Expensing stock options was supposed to provide a clear, consistent picture of earnings that can be compared across companies and industries. But that goal may now be fading.
The Motley Fool January 6, 2005 Rich Smith	Cellular Consolidation Continues Alltel is acquiring Western Wireless. Alltel shares are down more than 3%.
The Motley Fool January 6, 2005 Tim Beyers	Management Shuffle Matters Should Akamai Technology's management change affect its stock price? Yes. Management changes matter. If a company you're invested in shuffles the ranks, set forth to interview the new blood.
The Motley Fool January 6, 2005 W.D. Crotty	Is It Time to Sell Target? The retailer's lowered earnings expectations provide a reason to consider other options.
<Older 5131-5140 Newer> Return to current articles.